Fidelis Insurance Holdings Limi

Historical 13F Holders

Symbol
PLGO
CUSIP
G3398L118
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for G3398L118 since 12/18/2024, newest first.

Filer % of Class Filed
Pine Brook Road Advisors, L.P. 13G/A Amendment 3
7.0% 8/13/2026
Event 6/30/2026
Cooperman Leon G 13G/A Amendment 5 10.0% 8/11/2026
Event 8/4/2026
Cooperman Leon G 13G/A Amendment 4 9.9% 8/11/2026
Event 6/30/2026
SPFM Holdings, LLC 13G/A Amendment 3
7.0% 8/7/2026
Event 6/30/2026
Cooperman Leon G. 13G/A Amendment 3 9.2% 5/13/2026
Event 3/31/2026
CVC Capital Partners VI Ltd 13G/A Amendment 4
0% 5/12/2026
Event 3/31/2026
LSV Asset Management 13G 5.7% 5/12/2026
Event 3/31/2026
SPFM Holdings, LLC 13G/A Amendment 2
7.8% 5/6/2026
Event 3/31/2026
Pine Brook Road Advisors, L.P. 13G/A Amendment 2
8.4% 4/24/2026
Event 3/31/2026
CVC Capital Partners VI Ltd 13G/A Amendment 3
8.3% 2/17/2026
Event 12/31/2025
Crestview Partners III GP, L.P. 13G/A Amendment 3
13.8% 2/17/2026
Event 12/31/2025
Cooperman Leon G. 13G/A Amendment 2 6.8% 2/17/2026
Event 12/31/2025
Cooperman Leon G. 13G/A Amendment 1 6.4% 10/15/2025
Event 9/30/2025
Cooperman Leon G. 13G 6.2% 8/27/2025
Event 6/10/2025
CVC Capital Partners VI Ltd 13G/A Amendment 2
11.6% 8/13/2025
Event 6/30/2025
Shelf Holdco II Ltd 13G/A Amendment 1
9.4% 7/10/2025
Event 6/20/2025
Crestview Partners III GP, L.P. 13G/A Amendment 2
12.9% 5/14/2025
Event 3/31/2025
Crestview Partners III GP, L.P. 13G/A Amendment 1
13.0% 2/14/2025
Event 12/31/2024
Abu Dhabi Investment Authority 13G/A Amendment 2
3.4% 2/11/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 11 79.8 k $1.90 M
2026 Q2 192 66.7 M $1.62 B
2026 Q1 164 69.0 M $1.32 B
2025 Q4 156 77.8 M $1.52 B
2025 Q3 149 81.1 M $1.47 B
2025 Q2 158 80.9 M $1.34 B
2025 Q1 161 83.7 M $1.36 B
2024 Q4 159 86.2 M $1.57 B
2024 Q3 129 78.0 M $1.41 B
2024 Q2 123 77.3 M $1.26 B
2024 Q1 111 77.6 M $1.51 B
2023 Q4 87 98.4 M $1.25 B
2023 Q3 71 46.1 M $676 M
2023 Q2 46 47.4 M $647 M